Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
Congressional resolution recognizing May as Month of Awareness for three focus diseases (Progressive Supranuclear Palsy, Corticobasal Degeneration, Multiple System Atrophy); efforts to increase public awareness of the diseases, impact on individuals and families, and need for improved diagnostics, care, and research. The HEALTHY BRAINS Act and issues related to neurodegenerative diseases, caregiving and investment in brain health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Expressing support for the designation of the month of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month".
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Expressing support for the designation of the month of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month".
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Expressing support for the designation of the month of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month".
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
A resolution expressing support for the designation of the month of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month".
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
A resolution expressing support for the designation of the month of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month".
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
A resolution expressing support for the designation of the month of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month".
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.